Home2024-05-09T21:51:49+00:00

Voyageur Pharmaceuticals is proud to
introduce our

2024 Product Lineup

Featuring

SmoothX®

SmoothHD® 105%

SmoothLD® 60%

VisionHD® 98%

VisionLD® 96%

V-Gas®

Committed to building a better world

Voyageur Pharmaceuticals owns the only sustainable natural resource of pharmaceutical-grade barium and iodine in the world, ensuring decades of supply for medical imaging.

Voyageur Overview

Innovation in contrast media

2017

Founded

Calgary, Alberta

Headquarters

Diagnostic Imaging

Therapeutic Area

Contrast Agents

Product

Stock Quote

Click Here to view our current stock price.

Products

SmoothX (2% w/v)

Voyageur’s SmoothX (2%w/v) is a contrast medium for use in Computed Tomography (CT) of the gastrointestinal tract. Our barium supports high-quality imaging with reproducible results for accurate diagnosis and image comparison. In clinical tests a majority of patients preferred the taste of SmoothX over the product currently used in CT imaging.

SmoothHD® (105% w/v)

Designed for upper GI esophagogram and double contrast studies of the upper and lower gastrointestinal tract and colon,  SmoothHD delivers unmatched clarity and detail with its high-density (105% w/v, 58% w/w) barium suspension formulation, catering to the diagnostic needs of both adults and children.

SmoothLD® (60% w/v)

Offering a low-density (60% w/v) barium suspension solution, SmoothLD is tailored for single contrast radiographic examinations of the esophagus, stomach, and small bowel to visualize the gastrointestinal (GI) tract, providing reliable results for patients across all age groups.

VisionHD® (98% w/w)

Engineered as a high-density (98% w/w) barium powder suspension, VisionHD is tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. For both adults and children.

VisionLD® (96% w/w)

Boasting exceptional versatility, VisionLD is a high-density (57% w/v to 156% w/v) barium powder suspension for single contrast radiographic examinations of the esophagus, stomach, duodenum and small bowel to visualize the gastrointestinal tract (GI) in adult and pediatric patients.

V-Gas®

Under Development: In addition to the existing product lineup, Voyageur is actively developing V-Gas Effervescent Granules (4g), an innovative antacid and antiflatulent solution poised to alleviate common digestive discomforts while also serving as an integral component in double contrast studies. V-Gas is indicated for use in adults and children.

Corporate Presentation

The Latest News

Go to Top